J&J’s Darzalex nets first self-administered cancer injectable approval.
Share this article
Corporate
Score 65
Bullish
J&J’s Darzalex nets first self-administered cancer injectable approval
Mar 27, 2026 16:58 UTC
JNJ, XLV, AMGN
Short term
Related Articles
Score 35
State Street’s Tiny Fee Cut Is Paying Off Big Time
Mar 27, 19:24
Score 75
Recordati sizes up €10.9bn CVC Capital acquisition offer
Mar 27, 17:51
Score 35
Bearish
MicroStrategy director sells company shares as stock dips
Mar 27, 17:49
Score 85
Bullish
Corebridge Financial Unveils Transformational All-Stock Merger With Equitable, Targets $500M Synergies
Mar 27, 17:42
Stay Ahead of the Markets
Join thousands of traders using AI-powered market intelligence. Get personalized insights, real-time alerts, and advanced analysis tools.